摘要 |
<p>A method of predicting responsiveness to interferon treatment of a subject diagnosed with multiple sclerosis or infected with HCV type 2, 3 or 4, comprising comparing a level of expression in a cell of the subject of IFI6, OAS2, ISG15, OAS3 and IFIT1 genes to a reference expression data of said genes obtained from at least one interferon responder subject and/or at least one interferon non-responder subject, thereby predicting the responsiveness of the subject to interferon treatment.</p> |